BIO-key (NASDAQ: BKYI) will host its Q1’26 investor call and webcast on Monday, May 18th at 10 a.m. ET. Chairman & CEO Mike DePasquale and CFO Cecilia Welch will lead the presentation and Q&A.
The event includes phone dial-in, live webcast, and a three-month replay.
Loading...
Loading translation...
Positive
None.
Negative
None.
News Market Reaction – BKYI
-34.84%5.1x vol
10 alerts
-34.84%Session close to close
-29.7%Trough in 2 hr 51 min
$4.35MMarket Cap
5.1xRel. Volume
In the May 12 session, BKYI declined 34.84%, reflecting a significant negative market reaction.
Argus tracked a trough of -29.7% from its starting point during tracking.
Our momentum scanner triggered 10 alerts that day, indicating notable trading interest and price volatility.
Trading volume was exceptionally heavy at 5.1x the daily average, suggesting significant selling pressure.
The stock dropped -34.8% in the session following this news. A negative reaction despite this routin...
Analysis
The stock dropped -34.8% in the session following this news. A negative reaction despite this routine webcast notice would fit a pattern where structural and compliance concerns have overshadowed otherwise neutral or positive catalysts. The shares remained far below their 52-week high and recently completed a 1-for-10 reverse split, which previously saw a -14.32% move. Such a backdrop can amplify downside when investors focus on balance sheet, listing status, or governance risks.
Key Figures
Investor call date:Monday, May 18th at 10 a.m. ETU.S. dial-in:1-877-418-5460International dial-in:1-412-717-9594+5 more
8 metrics
Investor call dateMonday, May 18th at 10 a.m. ETQ1’26 investor webcast schedule
U.S. dial-in1-877-418-5460Q1’26 investor call access
International dial-in1-412-717-9594Q1’26 investor call access
Announced 2025 year-end investor call with webcast and replay details.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Pattern Detected
Recent news shows price declines on structural and compliance items (reverse split, Nasdaq notice) and gains on growth/profitability messaging, with one prior investor-call announcement drawing a positive move.
Recent Company History
Over the last few months, BIO-key has focused on balance sheet repair and listing compliance while signaling improving operations. A 1-for-10 reverse split and Nasdaq non-compliance notice weighed on the stock, while guidance for a 50% first-half revenue increase and expected profitability in 1H 2026 supported positive reactions. Prior call announcements, like the March 31, 2026 year-end investor call, also saw constructive trading. Today’s Q1’26 webcast notice fits this pattern of regular investor communications around operational updates.
Key Terms
identity and access management (iam), biometric authentication, multi-factor, on-premise
4 terms
identity and access management (iam)technical
"a global leader in Identity and Access Management (IAM) and biometric authentication"
Identity and access management (IAM) is the set of tools and practices a company uses to control who can enter its digital systems and what they can do, like assigning and checking virtual keys for employees, contractors and customers. Investors care because strong IAM reduces the risk of costly data breaches, regulatory fines and downtime, while weak IAM can damage trust, trigger expenses and harm a company’s valuation.
biometric authenticationtechnical
"leader in Identity and Access Management (IAM) and biometric authentication technologies"
Biometric authentication uses a person’s unique physical or behavioral traits—such as fingerprints, facial features, iris patterns, or voice—to verify identity instead of passwords or codes. For investors, it matters because faster, more secure login methods can boost customer trust and reduce fraud-related costs, while also creating opportunities and risks around technology adoption, data privacy rules, and the companies that build or supply the biometric systems.
multi-factortechnical
"biometric-centric, multi-factor identity and access management (IAM) software securing access"
Multi-factor describes an investment approach or model that looks at several different characteristics of stocks or bonds—such as price levels, recent performance, company size, or profit quality—at the same time to decide what to buy or sell. It matters to investors because combining factors is like using a multi-point checklist instead of a single rule: it spreads risk, can smooth returns across market swings, and helps explain why some investments perform differently than others.
on-premisetechnical
"Its cloud-hosted or on-premise PortalGuard IAM solution provides cost-effective"
On-premise refers to software, hardware, or systems that are installed and operated directly within a company's physical location, such as its offices or data centers. Unlike cloud-based solutions that are accessed over the internet, on-premise setups require organizations to manage and maintain their own infrastructure. For investors, understanding on-premise options can indicate a company's investment in its own technology infrastructure and potential cost or security considerations.
HOLMDEL, N.J., May 12, 2026 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ: BKYI), a global leader in Identity and Access Management (IAM) and biometric authentication technologies, will host its Q1’26 investor call and webcast on Monday, May 18th at 10 a.m. ET. Mike DePasquale, Chairman & CEO and Cecilia Welch, CFO will lead the call and Q&A session.
BIO-key is revolutionizing authentication and cybersecurity with biometric-centric, multi-factor identity and access management (IAM) software securing access for over forty million users. BIO-key provides phoneless, tokenless, and passwordless biometric options, enabling customers to choose the right authentication factors for their diverse use cases. Its cloud-hosted or on-premise PortalGuard IAM solution provides cost-effective, easy-to-deploy, convenient, and secure access to computers, information, applications, and high-value transactions.
Investor Contacts William Jones, David Collins Catalyst IR BKYI@catalyst-ir.com 212-924-9800
FAQ
When is the BIO-key (NASDAQ: BKYI) Q1 2026 investor webcast?
The BIO-key Q1 2026 investor webcast is scheduled for Monday, May 18th at 10 a.m. ET. According to BIO-key, the event will feature management commentary and a Q&A session for investors and analysts.
How can investors access the BIO-key (BKYI) Q1 2026 earnings call?
Investors can access the BIO-key Q1 2026 call via dial-in or webcast. According to BIO-key, U.S. callers dial 1-877-418-5460, international callers dial 1-412-717-9594, and a live webcast link will also be provided.
Will a replay be available for the BIO-key (BKYI) Q1 2026 investor webcast?
Yes, a replay of the BIO-key Q1 2026 webcast will be available. According to BIO-key, the webcast replay will be accessible for three months, and an audio replay is offered at 1-855-669-9658 or 1-412-317-0088 with code 1165470.
Who will present during the BIO-key (BKYI) Q1 2026 investor call?
The BIO-key Q1 2026 investor call will be led by Chairman & CEO Mike DePasquale and CFO Cecilia Welch. According to BIO-key, they will provide business updates and answer investor questions during the Q&A session.
What does BIO-key (BKYI) do in biometric identity and authentication?
BIO-key provides biometric-centric, multi-factor identity and access management software for over forty million users. According to BIO-key, its PortalGuard IAM platform offers phoneless, tokenless, and passwordless options via cloud or on-premise deployment for secure access to systems and high-value transactions.
How can investors follow BIO-key (BKYI) for updates and IR news?
Investors can follow BIO-key through several social and IR channels. According to BIO-key, key options include X handles @BIOkeyIntl and @BIO_keyIR, StockTwits BIO_keyIR, plus corporate pages on Facebook and LinkedIn for broader company and product updates.
